De novo mutation in the KCNQ1 gene causal to Jervell and Lange-Nielsen syndrome.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 24125535)

Published in Clin Genet on November 14, 2013

Authors

J Y Al-Aama1, S Al-Ghamdi, A Y Bdier, A A M Wilde, Zahurul A Bhuiyan

Author Affiliations

1: Department of Genetic Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia; Princess Al Jawhara Albrahim Center of Excellence in Research of Hereditary Disorders, King Abdulaziz University, Jeddah, Saudi Arabia.

Articles citing this

Congenital Long QT Syndrome: An Update and Present Perspective in Saudi Arabia. Front Pediatr (2013) 0.81

Articles by these authors

(truncated to the top 100)

Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation (2006) 3.44

The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol (2010) 2.56

Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation (2010) 2.53

Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med (2008) 2.34

Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology (2008) 2.21

A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc Res (2003) 1.89

Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators? Neth Heart J (2011) 1.89

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol (2011) 1.89

Bibliometric data in clinical cardiology revisited. The case of 37 Dutch professors. Neth Heart J (2011) 1.79

Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet (2005) 1.78

The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. J Am Coll Cardiol (2009) 1.70

Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties. Acta Physiol Scand (2005) 1.67

Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family. Heart Rhythm (2006) 1.57

Increased DNA damage sensitivity of Cornelia de Lange syndrome cells: evidence for impaired recombinational repair. Hum Mol Genet (2007) 1.56

Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm (2008) 1.56

[Initial diagnostic strategy in the case of transient losses of consciousness: the importance of the medical history]. Ned Tijdschr Geneeskd (2003) 1.55

Genetic knowledge and counselling skills of Dutch cardiologists: sufficient for the genomics era? Eur Heart J (2003) 1.52

[Genetic identification of patients and families with a long-QT syndrome: large regional differences in the result of 10 years]. Ned Tijdschr Geneeskd (2007) 1.46

Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene. Heart Rhythm (2011) 1.46

The works of Dirk Durrer (1918-1984). Neth Heart J (2012) 1.39

[Medication for ADHD and the risk of cardiovascular mortality]. Ned Tijdschr Geneeskd (2006) 1.39

The Hirsch-index: a simple, new tool for the assessment of scientific output of individual scientists: The case of Dutch professors in clinical cardiology. Neth Heart J (2009) 1.30

Novel calmodulin mutations associated with congenital arrhythmia susceptibility. Circ Cardiovasc Genet (2014) 1.27

HERG channel (dys)function revealed by dynamic action potential clamp technique. Biophys J (2004) 1.20

The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome. J Med Genet (2003) 1.13

The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol (2009) 1.11

Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm (2012) 1.06

Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives. Circ Arrhythm Electrophysiol (2012) 1.05

Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome. Cardiovasc Res (2005) 1.03

Cten signals through integrin-linked kinase (ILK) and may promote metastasis in colorectal cancer. Oncogene (2011) 1.02

Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology (2009) 1.00

Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Ann Med (2004) 0.98

Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique. J Physiol (2005) 0.95

Fever-triggered ventricular arrhythmias in Brugada syndrome and type 2 long-QT syndrome. Neth Heart J (2010) 0.94

First experience with the wearable cardioverter defibrillator in the Netherlands. Neth Heart J (2012) 0.94

Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy. Neth Heart J (2013) 0.94

Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes. Neth Heart J (2014) 0.93

ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease: relation with plasma neurohormones and MRI parameters. Heart (2002) 0.92

Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands. Neth Heart J (2010) 0.92

The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease. Neth Heart J (2011) 0.91

Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Neth Heart J (2010) 0.91

Rationale and design of the CAREFUL study : The yield of CARdiogenetic scrEening in First degree relatives of sudden cardiac and UnexpLained death victims <45 years. Neth Heart J (2010) 0.90

Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy. Neurology (2011) 0.90

IKs in heart and hearing, the ear can do with less than the heart. Circ Cardiovasc Genet (2013) 0.89

Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation. Cardiovasc Res (2007) 0.88

Knowledge and attitudes towards AIDS among Saudi and non-Saudi bus drivers. East Mediterr Health J (2002) 0.88

Can parents adjust to the idea that their child is at risk for a sudden death?: Psychological impact of risk for long QT syndrome. Am J Med Genet A (2005) 0.88

High distress in parents whose children undergo predictive testing for long QT syndrome. Community Genet (2005) 0.87

Prognostic value of microvolt T-wave alternans in a real-world ICD population. Twente ICD Cohort Studie (TICS). Neth Heart J (2014) 0.87

Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: a survey. Clin Genet (2005) 0.85

Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation? Neth Heart J (2007) 0.84

Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers. Neth Heart J (2009) 0.84

Pregnancy and the risk of torsades de pointes in congenital long-QT syndrome. Neth Heart J (2008) 0.83

Human keratinocytes produce the complement inhibitor factor I: Synthesis is regulated by interferon-gamma. Mol Immunol (2007) 0.83

A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome. PLoS One (2013) 0.83

Therapeutic efficacy of chloroquine against uncomplicated, Plasmodium falciparum malaria in south-western Saudi Arabia. Ann Trop Med Parasitol (2001) 0.82

Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophy. Neth Heart J (2007) 0.81

GENCOR: a national registry for patients and families suffering from a familial heart disease in the Netherlands. Neth Heart J (2006) 0.81

Netherlands Heart Journal: accepted into PubMed Central! Neth Heart J (2006) 0.81

Recurrent and founder mutations in inherited cardiac diseases in the Netherlands. Neth Heart J (2009) 0.80

Founder mutations in the Netherlands: familial idiopathic ventricular fibrillation and DPP6. Neth Heart J (2011) 0.80

Letter regarding article by McNair et al, "SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia". Circulation (2005) 0.80

Recurrent and Founder Mutations in the Netherlands: the Long-QT Syndrome. Neth Heart J (2010) 0.80

p.L1612P, a novel voltage-gated sodium channel Nav1.7 mutation inducing a cold sensitive paroxysmal extreme pain disorder. Anesthesiology (2015) 0.79

[Hypertrophic cardiomyopathy: a genetically-carried heart disease]. Ned Tijdschr Geneeskd (2002) 0.79

Percutaneous pulmonary valve replacement: a new development in the lifetime strategy for patients with congenital heart disease. Neth Heart J (2007) 0.79

The impacts of dental filling materials on RapidArc treatment planning and dose delivery: challenges and solution. Med Phys (2013) 0.78

SCN5A mutations in atrial fibrillation. Heart Rhythm (2010) 0.78

A large family characterised by nocturnal sudden death. Neth Heart J (2002) 0.77

T-wave alternans in a patient with long-QT syndrome type 3. Neth Heart J (2006) 0.77

Arrhythmogenic right ventricular cardiomyopathy: asymptomatic to life threatening as illustrated by the cases of two sisters. Neth Heart J (2007) 0.77

Towards a better risk stratification for sudden cardiac death in patients with structural heart disease. Neth Heart J (2009) 0.77

Flush after syncope: not always an arrhythmia. J Cardiovasc Electrophysiol (2006) 0.77

Genetic predisposition for sudden cardiac death in myocardial ischaemia: the Arrhythmia Genetics in the NEtherlandS study. Neth Heart J (2011) 0.76

Rationale of the SEAS study: Serial Echocardiography After Subarachnoid haemorrhage, a prospective national, multicentre, multidisciplinary, cohort study to evaluate cardiac abnormalities following intracranial haemorrhage. Neth Heart J (2006) 0.75

An extended family suddenly confronted with a life-threatening hereditary arrhythmia. Neth Heart J (2005) 0.75

Recent breakthroughs in the genetics of atrial fibrillation. Neth Heart J (2003) 0.75

The ECG of a (cardio)myopathy? Neth Heart J (2005) 0.75

'Brugada ECG' elicited by imipramine overdose. Neth Heart J (2004) 0.75

Right you are. Neth Heart J (2005) 0.75

Should I be worried? Neth Heart J (2006) 0.75

Familial primary arrhythmia syndromes: Nice to know or need to know. Neth Heart J (2002) 0.75

Recommendations and cardiological evaluation of athletes with arrhythmias: Part 2. Neth Heart J (2004) 0.75

Recommendations and cardiological evaluation of athletes with arrhythmias: Part 1. Neth Heart J (2004) 0.75

Desmosomal mutations across the fence. Heart Rhythm (2011) 0.75

ECG screening of newborns to avoid sudden infant death syndrome? Neth Heart J (2006) 0.75

Nightly phenomena, day time work? Neth Heart J (2004) 0.75

Not just any ICD device in patients with long-QT syndrome. Neth Heart J (2007) 0.75

It's not what you think it is. Neth Heart J (2005) 0.75

Primary ventricular fibrillation in acute myocardial infarction: an inherited disease? Neth Heart J (2001) 0.75

Brugada syndrome. Eur Heart J (2002) 0.75

Primary prevention: prime time?: ICD trials (and tribulations). Neth Heart J (2004) 0.75

TDI-echocardiography: a new screening tool for long QT syndrome? Eur J Echocardiogr (2003) 0.75

Palpitations and dizziness in a 65-year-old man. Neth Heart J (2006) 0.75

A fainting lady with some extrasystoles. Neth Heart J (2004) 0.75

COMPANION - a friend indeed. Neth Heart J (2003) 0.75

Case histories: increasing role for major journals. Neth Heart J (2009) 0.75

Diversity in cardiac sodium channel disease phenotype in transgenic mice carrying a single SCN5A mutation. Neth Heart J (2007) 0.75

One more time: bibliometric analysis of scientific output remains complicated. Neth Heart J (2011) 0.75

Cardiogenetic counselling in a non-university hospital. Neth Heart J (2007) 0.75